ARTICLE | Clinical News
Stelara ustekinumab regulatory update
September 21, 2015 7:00 AM UTC
In June, the European Commission approved an expanded label for Stelara ustekinumab from Johnson & Johnson’s Janssen-Cilag International N.V. unit to treat moderate to severe plaque psoriasis to inclu...